Hurry up!
: : Get The Offer
Unlimited Access Step ( one, two and three ).
Priority Access To New Features.
Free Lifetime Updates Facility.
Dedicated Support.
1
Question:

A 46-year-old man comes to the emergency department with flank pain and hematuria.  The pain is similar to several previous episodes of kidney stones.  Abdominal imaging reveals a radiopaque calculus in the right ureter.  The patient is admitted to the hospital and given intravenous hydration and analgesics.  He subsequently passes the stone with rapid relief of his symptoms.  Chemical analysis reveals that the stone is composed primarily of calcium oxalate.  Which of the following medications is most likely to prevent recurrent stone formation in this patient?

Hurry up!
: : Get The Offer
Unlimited Access Step ( one, two and three ).
Priority Access To New Features.
Free Lifetime Updates Facility.
Dedicated Support.


Explanation:

There are many explanatory sources, such as pictures, videos, and audio clips to explain these explanations and questions and explain the answers, but you must subscribe first so that you can enjoy all these advantages. We have many subscription plans at the lowest prices. Don't miss today's offer. Subscribe

Show Explanatory Sources

Hypercalciuria increases the formation of calcium (calcium oxalate and calcium phosphate) stones, the most common types of kidney stone.  In patients with recurrent calcium nephrolithiasis, thiazide diuretics can help prevent stone formation by decreasing urine Ca2+ excretion.

Thiazides increase Ca2+ reabsorption through 2 major mechanisms:

  1. Inhibition of the Na+/Cl cotransporter on the apical side of distal convoluted tubule cells decreases intracellular Na+ concentrations.  This activates the basolateral Na+/Ca2+ antiporter, which pumps Na+ into the cell in exchange for Ca2+.  The resulting decrease in intracellular Ca2+ concentration enhances luminal Ca2+ reabsorption across the apical membrane.
  2. Hypovolemia induced by thiazides increases Na+ and H2O reabsorption in the proximal tubule, leading to a passive increase in paracellular Ca2+ reabsorption.

(Choice A)  Acetazolamide is a carbonic anhydrase inhibitor that acts on the proximal convoluted tubule to cause bicarbonate wasting, raising urine pH and decreasing the risk of uric acid stones.  However, the resulting systemic acidosis may increase release of calcium phosphate from bone, which is then cleared by the kidneys.  Some studies have found that acetazolamide use may raise the risk of calcium stone formation.

(Choice B)  Ca2+ reabsorption in the loop of Henle occurs through both the transcellular and paracellular pathways.  Paracellular Ca2+ reabsorption depends on concurrent, transcellular Na+/K+/Cl reabsorption.  Loop diuretics (eg, furosemide) block the Na-K-2Cl cotransporter and increase urinary Ca2+ excretion.

(Choice D)  Mannitol is an osmotic diuretic.  It is not used as maintenance therapy for any indication as it causes volume depletion and hypernatremia with prolonged use.  It has no effect on Ca2+ homeostasis.

(Choice E)  Triamterene and amiloride are potassium-sparing diuretics that inhibit Na+ reabsorption in the collecting duct by blocking the epithelial sodium channel.  This decreases net Na+/K+ exchange, reducing serum K+ losses.

Educational objective:
Thiazide diuretics effectively increase renal calcium reabsorption.  In patients with recurrent calcium nephrolithiasis, thiazide diuretics can help prevent stone formation by decreasing urine Ca2+ excretion.